LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that its Venezuelan operating affiliate, LataMed AI VE, will be featured in an interview in ES Salud Magazine, a healthcare-focused publication. The feature is expected to be published in the July 2026 edition and will include an editorial profile and interview discussing the Company’s healthcare technology initiatives, digital healthcare ecosystem strategy, and ongoing efforts to improve healthcare accessibility throughout Latin America.
According to the Company, it has received a formal invitation from the publisher to participate in a broader editorial feature package expected to include coverage through both ES Salud Magazine and Eva’s Magazine. The feature is anticipated to be distributed through multiple print, digital, social media, and online publication channels. This increased visibility among healthcare professionals, industry participants, and other stakeholders is expected to provide an opportunity for LataMed AI to discuss its evolving healthcare platform.
Management stated that the feature will discuss the Company’s telehealth infrastructure, healthcare coordination technologies, payment accessibility initiatives, insurance integration opportunities, pharmacy-related services, and artificial intelligence-driven healthcare solutions currently under development. The feature is expected to highlight LataMed AI’s broader vision of developing an integrated healthcare ecosystem designed to improve accessibility, coordination, and engagement for patients, healthcare providers, and other stakeholders across emerging markets.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., commented: “We appreciate the opportunity to share our vision for technology-enabled healthcare solutions and discuss the initiatives we are currently advancing throughout Latin America. We believe healthcare accessibility, coordination, and patient engagement remain important challenges across many markets, and we welcome opportunities to participate in industry discussions regarding the role of technology in addressing those challenges.”
The Company expects the feature to be published during July 2026 and intends to provide additional updates once publication details have been finalized, including information regarding publication dates, online availability, print distribution, and access through the publication's online digital channels. For additional information, visit https://latamed.ai or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
This feature matters because it brings attention to the role of technology in addressing healthcare challenges in emerging markets. LataMed AI’s focus on telehealth infrastructure and AI-driven solutions could potentially improve accessibility and coordination for patients and providers in regions often underserved by traditional healthcare systems. The coverage in ES Salud Magazine may also increase the Company’s visibility among healthcare professionals and industry stakeholders, potentially leading to strategic partnerships and further development of its healthcare ecosystem.
